| Study |
Reference |
|
Battino (Epilepsy), 2024
|
Battino Risk of Major Congenital Malformations and Exposure to Antiseizure Medication Monotherapy. JAMA Neurol 2024; 81:481-489 Tomson T Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 2011;10:609-17
|
|
Christensen (Epilepsy) (Controls exposed to LTG), 2024
|
Christensen Prenatal exposure to antiseizure medications and fetal growth: a population-based cohort study from the Nordic countries. Lancet Reg Health Eur 2024; 38:100849
|
|
Christensen (Epilepsy) (Controls unexposed, general population), 2024
|
Christensen Prenatal exposure to antiseizure medications and fetal growth: a population-based cohort study from the Nordic countries. Lancet Reg Health Eur 2024; 38:100849
|
|
Hvas (Epilepsy) (Controls unexposed, disease free), 2000
|
Hvas Epilepsy and pregnancy: effect of antiepileptic drugs and lifestyle on birthweight. BJOG 2000; 107:896-902
|
|
Hvas (Epilepsy) (Controls unexposed, sick), 2000
|
Hvas Epilepsy and pregnancy: effect of antiepileptic drugs and lifestyle on birthweight. BJOG 2000; 107:896-902
|
|
Kini (Epilepsy) (Controls exposed to Lamotrigine, sick), 2007
|
Kini Influence of the MTHFR genotype on the rate of malformations following exposure to antiepileptic drugs in utero. Eur J Med Genet ; 50:411-20
|
|
Kini (Epilepsy) (Controls unexposed, disease free), 2007
|
Kini Influence of the MTHFR genotype on the rate of malformations following exposure to antiepileptic drugs in utero. Eur J Med Genet ; 50:411-20
|
|
Kini (Epilepsy) (Controls unexposed, sick), 2007
|
Kini Influence of the MTHFR genotype on the rate of malformations following exposure to antiepileptic drugs in utero. Eur J Med Genet ; 50:411-20
|
|
Thomas (Epilepsy) (Controls exposed to Lamotrigine, sick), 2021
|
Keni Teratogenicity of antiepileptic dual therapy: Dose-dependent, drug-specific, or both? Neurology 2018; 90:e790-e796 Thomas Malformation risk of antiepileptic drug exposure during pregnancy in women with epilepsy: Results from a pregnancy registry in South India. Epilepsia 2017; 58:274-281 Thomas Malformation risk of new anti-epileptic drugs in women with epilepsy; observational data from the Kerala registry of epilepsy and pregnancy (KREP). Seizure 2021; 93:127-132
|
|
Thomas (Epilepsy) (Controls exposed to LTG), 2022
|
Thomas, S.V. Differential impact of antenatal exposure to antiseizure medications on motor and mental development in infants of women with epilepsy Epileptic Disord. 2022; 24:531-.
|
|
Thomas (Epilepsy) (Controls unexposed, sick), 2021
|
Thomas Malformation risk of antiepileptic drug exposure during pregnancy in women with epilepsy: Results from a pregnancy registry in South India. Epilepsia 2017; 58:274-281 Thomas Malformation risk of new anti-epileptic drugs in women with epilepsy; observational data from the Kerala registry of epilepsy and pregnancy (KREP). Seizure 2021; 93:127-132
|
|
Thomas (Epilepsy) (Controls unexposed, sick), 2022
|
Thomas, S.V. Differential impact of antenatal exposure to antiseizure medications on motor and mental development in infants of women with epilepsy Epileptic Disord. 2022; 24:531-.
|
|
Trivedi (Epilepsy) (Controls exposed to Lamotrigine, sick), 2018
|
Trivedi Spontaneous fetal loss in women with epilepsy: prospective data from pregnancy registry in India. Epilepsy Res 2018; 146:50-53
|
|
Trivedi (Epilepsy) (Controls unexposed, sick), 2018
|
Trivedi Spontaneous fetal loss in women with epilepsy: prospective data from pregnancy registry in India. Epilepsy Res 2018; 146:50-53
|
|
Vajda (Epilepsy) (Controls exposed to Lamotrigine, sick), 2019
|
Vajda Antiepileptic drugs and foetal malformation: analysis of 20 years of data in a pregnancy register. Seizure 2019; 65:6-11
|
|
Vajda (Epilepsy) (Controls unexposed, sick), 2019
|
Vajda Antiepileptic drugs and foetal malformation: analysis of 20 years of data in a pregnancy register. Seizure 2019; 65:6-11
|
